Comparison of Clinical Outcomes According to High-protein Provision in Critically Ill Patients After Abdominal Surgery
1 other identifier
interventional
152
1 country
1
Brief Summary
Protein malnutrition in critically ill patients is a global concern due to its association with prolonged hospital stays, and higher morbidity rates. Patients who undergo abdominal surgery are particularly vulnerable due to alterations in gastrointestinal function and prolonged fasting. Despite the significance of proper nutrition, the optimal target of protein supplementation remains controversial. The investigators aimed to evaluate the effects of high protein provision, targeting a protein intake of at least 1.5 g/kg/day for the first 3 days after abdominal surgery, on 6-month mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2024
CompletedFirst Posted
Study publicly available on registry
June 13, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
ExpectedJune 13, 2024
June 1, 2024
1.5 years
June 5, 2024
June 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
6-month mortality rate
Proportion of patients who died within 6 months after surgery among participants
Participants were followed up to 180 days immediately after the surgery
Secondary Outcomes (3)
30-day mortality rate
Participants were followed up to 30 days immediately after the surgery
90-day mortality rate
Participants were followed up to 90 days immediately after the surgery
Incidence of postoperative complications
Participants were followed during hospitalization (up to 14 days)
Study Arms (2)
Active protein supplementation
EXPERIMENTALThe participants in active nutritional supplementation arm received nutritional support targeting specific protein (over 1.5 g/kg/day), with consultation from the nutritional support team and the initiation of nutritional supplementation on the same day as intensive care unit admission.
Conventional protein supplementation
EXPERIMENTALThe participants in conventional protein supplementation arm underwent conventional nutrition management without specific protein targets, but less than 1.5 g/kg/day.
Interventions
The participants in active nutritional supplementation arm received consultation from the nutritional support team (NST) upon ICU admission, and nutritional supplementation was initiated on the same day. NST is a multidisciplinary support team comprised of physicians, nurses, dietitians, and pharmacists, which assesses the nutritional status of patients, and provides recommendations for nutritional therapy. Targets in the participants in active protein supplementation arm were protein supplementation at over 1.5 g/kg/day during first 3 days after ICU admission. Actual body weight was used as the body weight for patients with a percent of ideal body weight (PIBW) of less than 120%, while adjusted body weight was used for patients with a PIBW greater than or equal to 120%.
The participants in conventional protein supplementation arm received conservative nutritional management without specific protein targets.
Eligibility Criteria
You may qualify if:
- Patients admitted after abdominal surgery to our institution's surgical ICU
- They were enrolled regardless of the surgical method, either open, laparoscopy, or robotic.
You may not qualify if:
- aged under 18 years
- underwent surgery under local or regional anesthesia
- pregnant
- readmitted to the ICU due to any cause
- diagnosed with renal failure and receiving renal replacement therapy
- patients diagnosed with multiorgan failure, represented by a high Sequential Organ Failure Assessment (SOFA) score (≥9) upon ICU admission
- failed to provide informed consent, or with 'do-not-resuscitate' status.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital
Seoul, Seocho-gu, Banpo-dong Banpodaero 222, 137-701, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hye sung Kim
The Catholic University of Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 5, 2024
First Posted
June 13, 2024
Study Start
July 1, 2024
Primary Completion
January 1, 2026
Study Completion (Estimated)
June 1, 2027
Last Updated
June 13, 2024
Record last verified: 2024-06